Israel's BiomX raises $24 mln in private funding round: Reuters
BiomX, which is developing drugs using microbiome bacteria, said on Monday it raised $24 million in an early stage funding round led by OrbiMed, Jonhnson & Johnson Innovation and Takeda Ventures.
16 May 2017•1 min read
